Motif ID: Foxi1_Foxo1
Z-value: 1.711


Transcription factors associated with Foxi1_Foxo1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Foxi1 | ENSMUSG00000047861.2 | Foxi1 |
Foxo1 | ENSMUSG00000044167.5 | Foxo1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxo1 | mm10_v2_chr3_+_52268337_52268388 | -0.44 | 3.8e-03 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 42.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
3.8 | 11.5 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
3.7 | 18.5 | GO:0015671 | oxygen transport(GO:0015671) |
3.2 | 9.6 | GO:0021557 | oculomotor nerve development(GO:0021557) |
2.9 | 8.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
2.7 | 8.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
2.4 | 12.2 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
2.0 | 5.9 | GO:0021759 | globus pallidus development(GO:0021759) |
1.9 | 16.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
1.8 | 5.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.7 | 5.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
1.7 | 5.0 | GO:0045004 | DNA replication proofreading(GO:0045004) |
1.6 | 4.9 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
1.6 | 7.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.6 | 4.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.5 | 3.0 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
1.4 | 7.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.4 | 2.8 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.3 | 4.0 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
1.3 | 14.0 | GO:0060539 | diaphragm development(GO:0060539) |
1.2 | 11.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.2 | 3.6 | GO:0071105 | response to interleukin-11(GO:0071105) |
1.2 | 3.5 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
1.2 | 20.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.1 | 12.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.1 | 4.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
1.1 | 2.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.1 | 3.3 | GO:0071649 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of somatostatin secretion(GO:0090274) |
1.1 | 19.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.1 | 4.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.1 | 8.6 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.1 | 3.2 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
1.0 | 17.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.0 | 2.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.0 | 2.9 | GO:2000850 | protein-chromophore linkage(GO:0018298) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.0 | 2.9 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
0.9 | 3.7 | GO:0044330 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.9 | 3.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.9 | 2.7 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.9 | 2.7 | GO:0097274 | urea homeostasis(GO:0097274) |
0.9 | 2.7 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.9 | 2.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.9 | 2.6 | GO:0032714 | negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-5 production(GO:0032714) trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.9 | 6.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.8 | 8.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.8 | 2.5 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.8 | 5.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.8 | 9.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.8 | 4.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.8 | 2.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.8 | 2.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.8 | 2.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.8 | 2.3 | GO:0021546 | rhombomere development(GO:0021546) |
0.8 | 3.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.8 | 3.0 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.7 | 4.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.7 | 1.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 2.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.7 | 1.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 5.7 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.7 | 2.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.7 | 3.6 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.7 | 2.1 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.7 | 2.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.7 | 2.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.7 | 5.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.7 | 3.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.7 | 2.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.7 | 2.0 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.7 | 10.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.7 | 2.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.7 | 7.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 1.3 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.6 | 2.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.6 | 0.6 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.6 | 2.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.6 | 1.9 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.6 | 4.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 8.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.6 | 3.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.6 | 1.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 2.9 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 5.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.6 | 2.9 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 4.6 | GO:0015074 | DNA integration(GO:0015074) |
0.6 | 2.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.6 | 11.4 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.6 | 2.8 | GO:1903598 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) positive regulation of gap junction assembly(GO:1903598) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.6 | 1.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.6 | 1.7 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) negative regulation of intestinal absorption(GO:1904479) regulation of intestinal lipid absorption(GO:1904729) |
0.6 | 5.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.5 | 14.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 2.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.5 | 11.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.5 | 2.7 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.5 | 5.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.5 | 4.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.5 | 9.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.5 | 3.1 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.5 | 1.5 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 1.5 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.5 | 7.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 2.0 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.5 | 2.0 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.5 | 1.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 4.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 7.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.5 | 3.5 | GO:0015669 | gas transport(GO:0015669) carbon dioxide transport(GO:0015670) |
0.5 | 6.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.5 | 12.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.5 | 2.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 1.9 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.5 | 1.0 | GO:0019230 | proprioception(GO:0019230) |
0.5 | 2.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.5 | 1.9 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 1.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.5 | 1.8 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 0.9 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.5 | 0.9 | GO:0010248 | B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 1.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 4.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.4 | 13.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.4 | 9.7 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.4 | 4.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.4 | 0.9 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 3.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 1.3 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.4 | 3.4 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 0.4 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.4 | 2.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.4 | 1.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.4 | 1.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.4 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 1.5 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.4 | 1.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 3.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.4 | 3.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 4.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 1.8 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.4 | 0.7 | GO:0036292 | DNA rewinding(GO:0036292) |
0.4 | 1.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 1.1 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.4 | 1.4 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
0.3 | 1.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.3 | 2.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 5.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 2.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.3 | 6.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 1.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 0.7 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 2.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 1.3 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.3 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 3.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 12.8 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 3.3 | GO:0043144 | snoRNA processing(GO:0043144) |
0.3 | 2.3 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.3 | 2.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 1.0 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.3 | 4.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 1.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 9.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 1.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.6 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 2.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 0.3 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.3 | 4.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 0.9 | GO:2000334 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.3 | 1.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 1.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 1.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 1.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.3 | 3.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.3 | 4.5 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 4.4 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 1.1 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.3 | 1.4 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 0.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 1.1 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 1.6 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.3 | 5.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.3 | 1.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.3 | 1.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 1.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 0.8 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.3 | 2.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 0.3 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.3 | 2.8 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.3 | 2.3 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 1.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 1.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.7 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 0.7 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 1.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 1.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.2 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 1.4 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.2 | 1.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 0.7 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 1.0 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.2 | 3.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.7 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.2 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 2.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.7 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 1.3 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.2 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 2.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 1.9 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.6 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 1.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.6 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 1.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 0.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 7.9 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 3.1 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.2 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.2 | 1.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 2.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 0.9 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 1.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.6 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 1.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 1.4 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.2 | 0.7 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.2 | 1.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 0.9 | GO:1904721 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.2 | 0.7 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.2 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 0.8 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 1.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 5.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.3 | GO:1904407 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.2 | 0.5 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.2 | 1.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.5 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 1.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 1.4 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 1.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 2.1 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.7 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.1 | 1.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.4 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 1.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.7 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 4.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 1.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 1.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.4 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.4 | GO:1902524 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.1 | 0.5 | GO:0021965 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) spinal cord ventral commissure morphogenesis(GO:0021965) notochord regression(GO:0060032) |
0.1 | 0.7 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.5 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.1 | 0.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.8 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 2.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 1.7 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 1.2 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.1 | 2.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 1.8 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.1 | 5.2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 2.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 2.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.7 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.1 | 2.0 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 2.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 2.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.3 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 1.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 1.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 3.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 1.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.4 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0009174 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate metabolic process(GO:0009129) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) pyrimidine nucleobase biosynthetic process(GO:0019856) UMP metabolic process(GO:0046049) |
0.1 | 4.1 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 1.0 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.3 | GO:0071287 | cellular response to manganese ion(GO:0071287) regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.6 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 2.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.7 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 1.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 3.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 10.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.1 | 0.3 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.1 | 1.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 1.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 1.9 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 1.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.4 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 2.8 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 1.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.2 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.1 | 3.1 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.4 | GO:0015822 | ornithine transport(GO:0015822) |
0.1 | 0.3 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.6 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 1.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.5 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.5 | GO:2000790 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.1 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 1.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 3.8 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 1.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.3 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.1 | 0.9 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.3 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.8 | GO:0032402 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 | 0.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 1.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 1.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.5 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.6 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 1.7 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 1.5 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 2.5 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 2.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 1.0 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 1.8 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 1.1 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 1.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.4 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.1 | 1.3 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 0.6 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.1 | 0.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.3 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 6.2 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.6 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.0 | 0.3 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.0 | 1.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.4 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.3 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.1 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.2 | GO:2000648 | positive regulation of stem cell proliferation(GO:2000648) |
0.0 | 0.5 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.3 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 1.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.4 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.3 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 1.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.6 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.4 | GO:0032147 | activation of protein kinase activity(GO:0032147) |
0.0 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.4 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 1.0 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.0 | 0.1 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 2.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 1.4 | GO:0021510 | spinal cord development(GO:0021510) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 1.0 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.7 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 1.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.2 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.2 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.0 | 1.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 1.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.0 | 0.2 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.3 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:1902255 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.0 | 0.3 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.2 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 3.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 16.9 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
3.8 | 18.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.9 | 15.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.8 | 3.5 | GO:0000799 | nuclear condensin complex(GO:0000799) |
1.6 | 4.8 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
1.5 | 4.6 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.5 | 9.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.5 | 13.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.2 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
1.2 | 7.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
1.1 | 5.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.1 | 4.4 | GO:0008623 | CHRAC(GO:0008623) |
1.0 | 14.7 | GO:0042555 | MCM complex(GO:0042555) |
0.9 | 10.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.9 | 2.7 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.8 | 4.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.8 | 3.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.8 | 5.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.8 | 3.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 5.0 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.6 | 3.2 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.6 | 1.9 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
0.6 | 2.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.6 | 2.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.6 | 4.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 2.8 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.5 | 26.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 3.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.5 | 1.5 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
0.5 | 4.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 1.4 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.5 | 1.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 2.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 4.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 1.3 | GO:0034657 | GID complex(GO:0034657) |
0.4 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.4 | 2.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 1.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.4 | 3.4 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 1.1 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.4 | 1.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 2.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 3.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.3 | 1.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 2.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 3.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 1.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 2.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 1.1 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 3.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 1.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 1.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 1.0 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 4.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 1.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 2.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 13.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 0.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.2 | 2.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.5 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.4 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 7.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 1.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 1.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 1.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.2 | 2.8 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 1.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 3.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 1.2 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.2 | 11.0 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 1.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 1.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.2 | 2.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 14.6 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 2.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 2.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 1.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 1.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 0.7 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.2 | 1.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 0.8 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
0.2 | 1.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 0.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 7.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 1.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 2.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 1.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 2.6 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 1.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 4.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 2.2 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 2.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 1.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 5.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 1.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.9 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 2.5 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 2.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 11.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 2.5 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 0.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.6 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 4.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 1.6 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 8.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 5.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.9 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.5 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
0.1 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.3 | GO:0070820 | dense core granule membrane(GO:0032127) tertiary granule(GO:0070820) |
0.1 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 2.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 9.3 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 2.5 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 6.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 2.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 3.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 4.3 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 6.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 2.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 1.2 | GO:0001741 | XY body(GO:0001741) |
0.1 | 6.5 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 4.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 3.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 11.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 2.4 | GO:0043034 | costamere(GO:0043034) |
0.1 | 3.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 2.6 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 1.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 4.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 1.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 1.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 1.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.6 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 2.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 2.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 3.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 1.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 1.0 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 1.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 5.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.5 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 0.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.0 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.0 | 2.1 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.3 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 3.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.0 | 0.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.3 | GO:0005814 | centriole(GO:0005814) |
0.0 | 2.4 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 54.9 | GO:0005634 | nucleus(GO:0005634) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 16.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
3.8 | 11.5 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
3.7 | 18.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
2.7 | 8.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
1.7 | 5.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.6 | 4.7 | GO:0016015 | morphogen activity(GO:0016015) |
1.6 | 4.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.5 | 7.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.4 | 9.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.4 | 5.5 | GO:0008142 | oxysterol binding(GO:0008142) |
1.2 | 32.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.2 | 3.6 | GO:0052740 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
1.1 | 11.7 | GO:0015250 | water channel activity(GO:0015250) |
1.0 | 2.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.0 | 2.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.9 | 3.6 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.9 | 3.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.9 | 8.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.8 | 2.5 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.8 | 5.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 4.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.8 | 2.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.7 | 3.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 5.2 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.7 | 2.9 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.7 | 3.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.7 | 2.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.7 | 2.0 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.7 | 10.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.6 | 3.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.6 | 2.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 1.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 3.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.6 | 1.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.6 | 7.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.6 | 3.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.6 | 2.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 2.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 3.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 3.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.6 | 2.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.6 | 2.8 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.5 | 1.1 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.5 | 2.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.5 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 1.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.5 | 1.5 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.5 | 1.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 2.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.5 | 23.1 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 2.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.5 | 1.5 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.5 | 1.9 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.5 | 7.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 2.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 1.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 5.1 | GO:0031957 | fatty acid transporter activity(GO:0015245) very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 3.2 | GO:0016918 | retinal binding(GO:0016918) |
0.5 | 1.4 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 3.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 7.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 12.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 2.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 1.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 5.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 3.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 10.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 2.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 1.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 6.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 6.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.4 | 2.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 1.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.4 | 8.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 1.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 1.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.4 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 1.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.4 | 1.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 14.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 0.7 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.3 | 1.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 1.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 1.0 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.3 | 1.0 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.3 | 1.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 8.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 3.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 6.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.3 | 3.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.3 | 0.3 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.3 | 1.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 1.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.3 | 2.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 4.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 2.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 0.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.3 | 1.1 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.3 | 5.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 6.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 7.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 1.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.3 | 1.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 0.8 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.3 | 1.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 4.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 8.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 1.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 1.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 1.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 2.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 4.7 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 1.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.7 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 0.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.2 | 2.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 2.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 3.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 6.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 0.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.2 | 1.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 41.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.5 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 3.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 1.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 2.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.2 | 0.6 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 1.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 4.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 1.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 1.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 1.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 1.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 2.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 1.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 1.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 4.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.7 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.2 | 2.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.8 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 0.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 0.5 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.2 | 2.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.2 | 2.2 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.8 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 0.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 14.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.1 | 0.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 1.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 1.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 6.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 6.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 1.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 1.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 9.2 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 3.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 2.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 1.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.8 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 1.1 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 2.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.5 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
0.1 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 1.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.6 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 2.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 4.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 3.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.3 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 4.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.8 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.3 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.1 | 1.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 5.4 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 1.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 4.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 13.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 1.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.7 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 5.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 6.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 11.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 1.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 1.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.3 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 2.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 2.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 2.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 3.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 3.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 1.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 2.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.1 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 2.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 3.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.6 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 2.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 3.1 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.0 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 1.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 1.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 1.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 1.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 1.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 5.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 1.2 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 6.8 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.7 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.0 | 0.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 2.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.2 | GO:0016859 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.0 | 0.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.5 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.0 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 0.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 16.9 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.1 | 3.4 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.9 | 12.7 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 21.7 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 46.8 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 10.9 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.4 | 12.4 | PID_ATR_PATHWAY | ATR signaling pathway |
0.4 | 12.6 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 11.0 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.4 | 18.3 | PID_PLK1_PATHWAY | PLK1 signaling events |
0.3 | 15.7 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.3 | 1.8 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
0.3 | 6.5 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 3.1 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.3 | 5.5 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 1.0 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 3.4 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 10.4 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 15.2 | PID_AP1_PATHWAY | AP-1 transcription factor network |
0.2 | 13.2 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 9.6 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
0.2 | 6.8 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 1.2 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 1.8 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
0.2 | 2.8 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.0 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 3.0 | PID_IL23_PATHWAY | IL23-mediated signaling events |
0.1 | 2.8 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
0.1 | 4.2 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 2.5 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.1 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.1 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 3.5 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.6 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.0 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 3.4 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.8 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.5 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.5 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.1 | PID_ATM_PATHWAY | ATM pathway |
0.1 | 5.1 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.7 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
0.1 | 1.1 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.6 | PID_IGF1_PATHWAY | IGF1 pathway |
0.1 | 1.6 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.1 | 1.1 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.4 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.1 | 1.2 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.6 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
0.0 | 1.7 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
0.0 | 2.0 | NABA_COLLAGENS | Genes encoding collagen proteins |
0.0 | 3.9 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.1 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.7 | PID_E2F_PATHWAY | E2F transcription factor network |
0.0 | 0.9 | ST_FAS_SIGNALING_PATHWAY | Fas Signaling Pathway |
0.0 | 2.7 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.3 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.5 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.2 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.3 | PID_EPO_PATHWAY | EPO signaling pathway |
0.0 | 0.3 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
0.0 | 0.3 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 2.3 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.6 | PID_NOTCH_PATHWAY | Notch signaling pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 10.5 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
1.0 | 4.0 | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.0 | 15.8 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
0.9 | 13.3 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.8 | 38.2 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
0.8 | 24.8 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.7 | 11.5 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 12.7 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
0.6 | 4.4 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 5.1 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.6 | 2.3 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
0.5 | 7.6 | REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.5 | 3.7 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
0.5 | 7.7 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 11.1 | REACTOME_KINESINS | Genes involved in Kinesins |
0.4 | 3.0 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 3.6 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
0.4 | 0.7 | REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.4 | 5.0 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 9.2 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 33.3 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 4.7 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.3 | 1.8 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 11.6 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 10.3 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 3.9 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 2.0 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 0.5 | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 2.9 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
0.2 | 11.1 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 0.8 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 6.5 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 15.3 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 8.3 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 8.4 | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 4.6 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 2.7 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.1 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.5 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 2.0 | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.5 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.7 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 5.9 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 4.8 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 8.9 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 4.5 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.2 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 11.4 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 4.0 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.8 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.0 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.6 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 2.0 | REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 2.4 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.2 | REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 2.5 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
0.1 | 1.8 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.6 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 6.5 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.4 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.7 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.0 | REACTOME_GAP_JUNCTION_TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.2 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.9 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.6 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 8.3 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.8 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 10.2 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.1 | 4.1 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.2 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 2.5 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.8 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.2 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 1.0 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 2.3 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.5 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.4 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.4 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.7 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.2 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 2.1 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.5 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.6 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.5 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
0.0 | 2.4 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.5 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.6 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 1.3 | REACTOME_IRON_UPTAKE_AND_TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.8 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.2 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.4 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.5 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.8 | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.6 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.7 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 1.1 | REACTOME_DIABETES_PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.2 | REACTOME_EXTENSION_OF_TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.3 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.7 | REACTOME_TRANSLATION | Genes involved in Translation |
0.0 | 0.3 | REACTOME_INTEGRATION_OF_PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.2 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.1 | REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.2 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.1 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.2 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 2.6 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME_REGULATION_OF_COMPLEMENT_CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.2 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |